title: The implications of using mutagenic primers in combination with Taq polymerase having proofreading activity.
authors.affiliation: Molecular Biology Department Research Center HYGEIA Antonis Papayiannis, 4 Erythrou Stavrou & Kifissias Ave., Maroussi 15123, Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Papadopoulou
authors.forename: V
authors.initials: V
authors.lastname: Metaxa-Mariatou
authors.forename: A
authors.initials: A
authors.lastname: Hatzaki
authors.forename: Th
authors.initials: T
authors.lastname: Hatzis
authors.forename: G
authors.initials: G
authors.lastname: Nasioulas
mesh_terms: D001483:Base Sequence; D002845:Chromatography; D002851:Chromatography, High Pressure Liquid; D004247:DNA / Q000737:chemistry / Q000378:metabolism; D004252:DNA Mutational Analysis; D017931:DNA Primers / Q000737:chemistry / Q000494:pharmacology*; D004262:DNA Restriction Enzymes / Q000378:metabolism; D004259:DNA-Directed DNA Polymerase / Q000737:chemistry; D005838:Genotype; D006720:Homozygote; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D020125:Mutation, Missense; D016133:Polymerase Chain Reaction; D011516:Prothrombin / Q000096:biosynthesis / Q000235:genetics*; D019914:Taq Polymerase / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D011516:Prothrombin; D004247:DNA; D019914:Taq Polymerase; D004259:DNA-Directed DNA Polymerase; D004262:DNA Restriction Enzymes